Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Cost of Revenue (2017 - 2025)

Neuronetics (STIM) has disclosed Cost of Revenue for 9 consecutive years, with $20.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 345.77% to $20.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $37.4 million, a 199.24% increase, with the full-year FY2024 number at $20.7 million, up 5.53% from a year prior.
  • Cost of Revenue was $20.2 million for Q3 2025 at Neuronetics, down from $20.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $20.3 million in Q2 2025 to a low of -$16.0 million in Q4 2023.
  • A 5-year average of $5.3 million and a median of $6.1 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: plummeted 519.29% in 2021, then soared 345.77% in 2025.
  • Neuronetics' Cost of Revenue stood at -$15.8 million in 2021, then skyrocketed by 127.82% to $4.4 million in 2022, then plummeted by 463.53% to -$16.0 million in 2023, then grew by 5.44% to -$15.1 million in 2024, then soared by 233.78% to $20.2 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Cost of Revenue are $20.2 million (Q3 2025), $20.3 million (Q2 2025), and $12.0 million (Q1 2025).